The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Cell-free nucleic acids as biomarkers in cancer patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Nuclear Acids In Human Blood Plasma.
Mandel, P., & Métais, P. (1948) · PubMed · Cited by 1,196
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Self-citationA novel and universal method for microRNA RT-qPCR data normalization
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-6-r64 · Cited by 1,079
Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
Lin, J.-C., Wang, W.-Y., Chen, K. Y., Wei, Y.-H., Liang, W.-M., Jan, J.-S., & Jiang, R.-S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032260 · Cited by 909
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Circulating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Self-citationHu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
Esteller, M., & Herman, J. G. (2002) · The Journal of Pathology · doi:10.1002/path.1024 · Cited by 743
Microsatellite alterations in serum DNA of head and neck cancer patients
Nawroz, H., Koch, W., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 658
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., & Yao, S. (1994) · PubMed · Cited by 530
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522
Chan, A. T. �., Lo, Y. M. D., Zee, B., Chan, L. Y. S., Ma, B. B. Y., Leung, S.-F., Mo, F., Lai, M., Ho, S., Huang, D. P., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.21.1614 · Cited by 452
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Self-citationCirculating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Self-citationSozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 421
Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Stroun, M. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04828.x · Cited by 414
The methyl-CpG binding domain and the evolving role of DNA methylation in animals
Hendrich, B., & Tweedie, S. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00080-5 · Cited by 399
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Grützmann, R., Molnar, B., Pilarsky, C., Habermann, J. K., Schlag, P. M., Saeger, H. D., Miehlke, S., Stolz, T., Model, F., Roblick, U. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003759 · Cited by 394
The Origin and Mechanism of Circulating DNA
STROUN, M., MAURICE, P., VASIOUKHIN, V., LYAUTEY, J., LEDERREY, C., LEFORT, F., ROSSIER, A., CHEN, X. Q., & ANKER, P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06608.x · Cited by 394
Leung, S. F., Zee, B. C.-Y., Ma, B. B. Y., Hui, E. P., Mo, F. K. F., Lai, M., Chan, K. C. A., Chan, L. Y. S., Kwan, W. H., Lo, Y. M. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7982 · Cited by 373
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
Umetani, N., Giuliano, A. E., Hiramatsu, S. H., Amersi, F., Nakagawa, T., Martino, S., & Hoon, D. S. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9493 · Cited by 351
Self-citationLo, Y. M. D., Chan, A. T. �., Chan, L. Y. S., Leung, S. F., Lam, C., Huang, D. P., & Johnson, P. J. (2000) · PubMed · Cited by 341
Flow cytometric analysis of circulating microparticles in plasma
Orozco, A. F., & Lewis, D. E. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20886 · Cited by 333
Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068577 · Cited by 331
Self-citationWolff, E. M., Byun, H.-M., Han, H. F., Sharma, S., Nichols, P. W., Siegmund, K. D., Yang, A. S., Jones, P. A., & Liang, G. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000917 · Cited by 308
Au, W., Pang, A. W. K., Choy, C., Chim, C. S., & Kwong, Y. (2004) · Blood · doi:10.1182/blood-2003-12-4197 · Cited by 306
Lecomte, T., Berger, A., Zinzindohoué, F., Micard, S., Landi, B., Blons, H., Beaune, P., Cugnenc, P., & Laurent‐Puig, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10526 · Cited by 292
Kefford, R., Arkenau, H., Brown, M. P., Millward, M., Infante, J. R., Long, G. V., Ouellet, D., Curtis, M., Lebowitz, P. F., & Falchook, G. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.8503 · Cited by 275
Active Alu retrotransposons in the human genome
Bennett, E. A., Keller, H., Mills, R. E., Schmidt, S., Moran, J. V., Weichenrieder, O., & Devine, S. E. (2008) · Genome Research · doi:10.1101/gr.081737.108 · Cited by 274
García-Olmo, D. C., Domínguez, C., García-Arranz, M., Anker, P., Stroun, M., García-Verdugo, J. M., & García-Olmo, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3513 · Cited by 267
Fiegl, H., Millinger, S., Mueller-Holzner, E., Marth, C., Ensinger, C., Berger, A., Klocker, H., Goebel, G., & Widschwendter, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2438 · Cited by 252
Molecular detection of genetic alterations in the serum of colorectal cancer patients.
Hibi, K., Robinson, C. R., Booker, S. V., Wu, L. J., Hamilton, S. R., Sidransky, D., & Jen, J. (1998) · PubMed · Cited by 236
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Schwarzenbach, H., Alix-Panabières, C., Müller, I., Letang, N., Vendrell, J.-P., Rebillard, X., & Pantel, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1910 · Cited by 235
Self-citationMethylation of Endogenous Human Retroelements in Health and Disease
Schulz, W. A., Steinhoff, C., & Florl, A. R. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31181-5_11 · Cited by 222
Castells, A., Puig, P., Móra, J., Boadas, J., Boix, L., Urgell, E., Solé, M., Capellà, G., Lluís, F., Fernández-Cruz, L., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.578 · Cited by 222
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
Yamamoto, Y., Kosaka, N., Tanaka, M., Koizumi, F., Kanai, Y., Mizutani, T., Murakami, Y., Kuroda, M., Miyajima, A., Kato, T., et al. (2009) · Biomarkers · doi:10.3109/13547500903150771 · Cited by 216
Kohler, C., Radpour, R., Barekati, Z., Asadollahi, R., Bitzer, J., Wight, E., Bürki, N., Diesch, C., Holzgreve, W., & Zhong, X. Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-105 · Cited by 215
Kristensen, L. S., & Hansen, L. L. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.121962 · Cited by 212
Quantitative Analysis of Circulating Mitochondrial DNA in Plasma
Chiu, R. W. K., Chan, L. Y. S., Lam, N. Y. L., Tsui, N. B. Y., Ng, E. K. O., Rainer, T. H., & Lo, Y. M. D. (2003) · Clinical Chemistry · doi:10.1373/49.5.719 · Cited by 208
Bastian, P. J., Palapattu, G. S., Lin, X., Yegnasubramanian, S., Mangold, L. A., Trock, B., Eisenberger, M. A., Partin, A. W., & Nelson, W. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2446 · Cited by 202
Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer
Jernimo, C., Usadel, H., Henrique, R., Silva, C., Oliveira, J., Lopes, C., & Sidransky, D. (2002) · Urology · doi:10.1016/s0090-4295(02)01949-0 · Cited by 201
Choi, J., Reich, C. F., & Pisetsky, D. S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02130.x · Cited by 198
Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
Schwarzenbach, H., Stoehlmacher, J., Pantel, K., & Goekkurt, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.025 · Cited by 193
Self-citationTänzer, M., Balluff, B., Distler, J., Hale, K., Leodolter, A., Röcken, C., Molnar, B., Schmid, R., Lofton-Day, C., Schuster, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009061 · Cited by 191
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000) · PubMed · Cited by 190
Nucleosomes in serum of patients with benign and malignant diseases
Holdenrieder, S., Stieber, P., Bodenm�ller, H., Busch, M., Fertig, G., F�rst, H., Schalhorn, A., Schmeller, N., Untch, M., & Seidel, D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<114::aid-ijc1020>3.0.co;2-q · Cited by 186
Kirk, G. D., Lesi, O. A., Mendy, M., Szymañska, K., Whittle, H., Goedert, J. J., Hainaut, P., & Montesano, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208732 · Cited by 181
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
Kopreski, M., Benko, F., Kwee, C., Leitzel, K., Eskander, E., Lipton, A., & Gocke, C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.551 · Cited by 172
Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma
Chan, K. C. A., Lai, P. B. S., Mok, T. S. K., Chan, H. L. Y., Ding, C., Yeung, S. W., & Lo, Y. M. D. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.104653 · Cited by 170
Plasma cell‐free DNA in ovarian cancer: An independent prognostic biomarker
Kamat, A. A., Baldwin, M., Urbauer, D., Dang, D., Han, L. Y., Godwin, A., Karlan, B. Y., Simpson, J. L., Gershenson, D. M., Coleman, R. L., et al. (2010) · Cancer · doi:10.1002/cncr.24997 · Cited by 169
Mori, T., O’Day, S. J., Umetani, N., Martinez, S. R., Kitago, M., Koyanagi, K., Kuo, C., Takeshima, T.-L., Milford, R., Wang, H.-J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9876 · Cited by 167
Self-citationWang, J., Hsieh, J., Chang, M., Huang, T., Chen, F., Cheng, T., Alexandersen, K., Huang, Y., Tzou, W., & Lin, S. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7366-8 · Cited by 167
Sturgeon, C. M., Hoffman, B. R., Chan, D. W., Ch'ng, S.-L., Hammond, E., Hayes, D. F., Liotta, L. A., Petricoin, E. F., Schmitt, M., Semmes, O. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.094144 · Cited by 166
Shinozaki, M., O'Day, S. J., Kitago, M., Amersi, F., Kuo, C., Kim, J., Wang, H.-J., & Hoon, D. S. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2120 · Cited by 164
Self-citationMicroRNAs as Novel Biomarkers for Breast Cancer
Heneghan, H., Miller, N., Lowery, A., Sweeney, K. J., & Kerin, M. J. (2009) · Journal of Oncology · doi:10.1155/2010/950201 · Cited by 153
Skvortsova, T. E., RYKOVA, E. Y., TAMKOVICH, S. N., Bryzgunova, O. E., Starikov, A. V., Kuznetsova, N. P., Vlassov, V. V., & Laktionov, P. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603117 · Cited by 150
Clinical Relevance of Circulating Nucleosomes in Cancer
Holdenrieder, S., Nagel, D., Schalhorn, A., Heinemann, V., Wilkowski, R., von Pawel, J., Raith, H., Feldmann, K., Kremer, A. E., Müller, S., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.012 · Cited by 148
Circulating DNA as a Possible Factor in Oncogenesis
Bendich, A., Wilczok, T., & Borenfreund, E. (1965) · Science · doi:10.1126/science.148.3668.374 · Cited by 147
Bearzatto, A., Conte, D., Frattini, M., Zaffaroni, N., Andriani, F., Balestra, D., Tavecchio, L., Daidone, M. G., & Sozzi, G. (2002) · PubMed · Cited by 144
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors
Zachariah, R. R., Schmid, S., Buerki, N., Radpour, R., Holzgreve, W., & Zhong, X. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181867bc0 · Cited by 142
Silva, J. M., Silva, J., Sánchez, A., Garcia, J. M., Domínguez, G., Provencio, M., Sanfrutos, L., Jareño, E., Colas, A., España, P., et al. (2002) · PubMed · Cited by 142
Circulating Nucleic Acids in Plasma and Serum
Swaminathan, R., & Butt, A. N. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.001 · Cited by 141
Ward, T. H., Cummings, J., Dean, E. J., Greystoke, A., Hou, J., Backen, A. C., Ranson, M., & Dive, C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604519 · Cited by 139
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
Widschwendter, A., Müller, H. M., Fiegl, H., Ivarsson, L., Wiedemair, A., Müller‐Holzner, E., Goebel, G., Marth, C., & Widschwendter, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0825-03 · Cited by 138
DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
Goessl, C. D., MÜLLER, M., Heicappell, R., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03863.x · Cited by 137
Circulating Nucleic Acids in Plasma and Serum: Recent Developments
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 137
Liggett, T., Melnikov, A. A., Yi, Q., Replogle, C., Brand, R. E., Kaul, K. L., Talamonti, M. S., Abrams, R. A., & Levenson, V. (2010) · Cancer · doi:10.1002/cncr.24893 · Cited by 136
Kim, B. K., Park, J. Y., Kim, D. Y., Kim, J. K., Kim, K. S., Choi, J. S., Moon, B. S., Han, K., Chon, C. Y., Moon, Y. M., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01625.x · Cited by 131
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma
Tangkijvanich, P., Hourpai, N., Rattanatanyong, P., Wisedopas, N., Mahachai, V., & Mutirangura, A. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.029 · Cited by 130
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
Swisher, E. M., Wollan, M., Mahtani, S. M., Willner, J. B., Garcia, R. L., Goff, B. A., & King, M. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.054 · Cited by 130
Kimura, H., Fujiwara, Y., Sone, T., Kunitoh, H., Tamura, T., Kasahara, K., & Nishio, K. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603428 · Cited by 128
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
Zheng, Y. G., Wu, J., Chen, Z., & Goodman, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20120 · Cited by 127
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
Catarino, R., Ferreira, M. M. F., Rodrigues, H., Coelho, A., Nogal, A., de Sousa, A., & Medeiros, R. (2008) · DNA and Cell Biology · doi:10.1089/dna.2008.0744 · Cited by 124
Ellinger, J., Haan, K., Heukamp, L. C., et al. (2007) · The Prostate · doi:10.1002/pros.20651 · Cited by 122
Ramírez, J. L., Rosell, R., Tarón, M., Sanchez-Ronco, M., Alberola, V., Peñas, R. D. L., Sánchez, J. M., Morán, T., Camps, C., Massutí, B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2905 · Cited by 122
Lei, K. I. K., Chan, L. Y. S., Chan, W. Y., Johnson, P. J., & Lo, Y. M. D. (2002) · PubMed · Cited by 122
Chun, F. K. ‐., Müller, I., Lange, I., et al. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06352.x · Cited by 120
Suitable reference genes for relative quantification of miRNA expression in prostate cancer
Fendler, A., Jung, M., Miller, K., Lein, M., Kristiansen, G., Erbersdobler, A., & Jung, K. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.11.076 · Cited by 120
Mehra, N., Penning, M. T., Maas, J., van Daal, N., Giles, R. H., & Voest, E. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1087 · Cited by 118
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
Sunami, E., Shinozaki, M., Higano, C. S., Wollman, R. C., Dorff, T. B., Tucker, S. J., Martinez, S. R., Singer, F. R., & Hoon, D. S. �. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.108498 · Cited by 117
Self-citationUtting, M., Werner, W., Dahse, R., Schubert, J., & Junker, K. (2002) · PubMed · Cited by 115
Human papillomavirus DNA in plasma of patients with cervical cancer
Pornthanakasem, W., Shotelersuk, K., Termrungruanglert, W., Voravud, N., Niruthisard, S., & Mutirangura, A. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-2 · Cited by 112
Ellinger, J., Albers, P., Müller, S. C., Von Ruecker, A., & Bastian, P. J. (2009) · BJU International · doi:10.1111/j.1464-410x.2008.08289.x · Cited by 112
Fujiwara, Y., Chi, D. D., Wang, H., Keleman, P., Morton, D. L., Turner, R. R., & Hoon, D. S. �. (1999) · PubMed · Cited by 112
Self-citationSzymańska, K., Lesi, O. A., Kirk, G. D., Sam, O., Tanière, P., Scoazec, J., Mendy, M. E., Friesen, M. D., Whittle, H. C., Montesano, R., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20103 · Cited by 109
Ryan, B. M., Lefort, F., McManus, R., Daly, J., Keeling, P. W. N., Weir, D. G., & Kelleher, D. (2002) · Gut · doi:10.1136/gut.52.1.101 · Cited by 109
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
Ellinger, J., Wittkamp, V., Albers, P., Perabo, F., Mueller, S. C., von Ruecker, A., & Bastian, P. J. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.118 · Cited by 108
Boddy, J., Gal, S., Malone, P. R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1237 · Cited by 108
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients
An, Q., Liu, Y., Gao, Y., Huang, J., Fong, X., Li, L., Zhang, D.-C., & Cheng, S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00496-2 · Cited by 106
He, Q., Chen, H., Bai, E., Luo, Y., Fu, R., He, Y.-S., Jiang, J., & Wang, H. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.05.018 · Cited by 106
Wang, S., An, T., Wang, J., Zhao, J., Wang, Z., Zhuo, M., Bai, H., Yang, L., Zhang, Y., Wang, X., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2672 · Cited by 105
R E Board, Ellison, G., Orr, M. C. M., Kemsley, K., McWalter, G., Blockley, L., Dearden, S. P., Morris, C., Ranson, M., Cantarini, M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605371 · Cited by 102
Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA.
Emlen, W., & Mannik, M. (1984) · PubMed Central · Cited by 101
Quantification of LINE1 in Circulating DNA as a Molecular Biomarker of Breast Cancer
Sunami, E., Vu, A., Nguyen, S. L., Giuliano, A. E., & Hoon, D. S. �. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.011 · Cited by 100
Self-citationKoyanagi, K., Mori, T., O'Day, S. J., Martinez, S. R., Wang, H.-J., & Hoon, D. S. �. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4198 · Cited by 100
Self-citationRole of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer
Allen, D. J., Butt, A., Cahill, D. J., Wheeler, M., Popert, R., & Swaminathan, R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.013 · Cited by 99
Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma
Melnikov, A. A., Scholtens, D. M., Godwin, A. K., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080072 · Cited by 96
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
Gautschi, O. P., Huegli, B., Ziegler, A., Gugger, M., Heighway, J., Ratschiller, D., Mack, P. C., Gumerlock, P. H., Kung, H., Stahel, R. A., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.008 · Cited by 95
Ellinger, J., Bastian, P. J., Haan, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23057 · Cited by 95
der Auwera, I. V., Elst, H., Laere, S. V., Maes, H., Huget, P., van Dam, P. A., Marck, E. A. V., Vermeulen, P. B., & Dirix, L. Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605013 · Cited by 94
Wang, J., Qin, Y., Li, B., Sun, Z.-L., & Yang, B. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.01.008 · Cited by 94
Coulet, F., Blons, H., Cabelguenne, A., Lecomte, T., Lacourreye, O., Brasnu, D. F., Beaune, P. H., Zucman‐Rossi, J., & Laurent‐Puig, P. (2000) · PubMed · Cited by 93
Amount of DNA in plasma and cancer risk: A prospective study
Gormally, E., Hainaut, P. L., Caboux, É., Airoldi, L., Autrup, H. N., MALAVEILLE, C., Dunning, A. M., GARTE, S. J., Matullo, G., Overvad, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20327 · Cited by 93
Lo, Y. M. D., Leung, S. F., Chan, L. Y. S., Lo, K. W., Zhang, J., Chan, A. T. �., LEE, J. C. K., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06597.x · Cited by 93
Ellinger, J., Müller, S. C., Wernert, N., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07613.x · Cited by 89
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Taback, B., Fujiwara, Y., Wang, H. J., Foshag, L. J., Morton, D. L., & Hoon, D. S. �. (2001) · PubMed · Cited by 89
Self-citationLaktionov, P. P., TAMKOVICH, S. N., RYKOVA, E. Y., Bryzgunova, O. E., Starikov, A. V., Kuznetsova, N. P., & Vlassov, V. V. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.034 · Cited by 88
Sharma, G., Mirza, S., Parshad, R., Srivastava, A., Gupta, S. D., Pandya, P., & Ralhan, R. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.05.001 · Cited by 88
Miura, N., Nakamura, H., Sato, R., Tsukamoto, T., Harada, T., Takahashi, S., Adachi, Y., Shomori, K., Sano, A., Kishimoto, Y., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00342.x · Cited by 86
Wimberger, P., Roth, C., Pantel, K., Kasimir‐Bauer, S., Kimmig, R., & Schwarzenbach, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25602 · Cited by 84
Self-citationRen, N., Qin, L., Tu, H., et al. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0049-5 · Cited by 83
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
Sharma, G., Mirza, S., Parshad, R., Srivastava, A., Gupta, S. D., Pandya, P., & Ralhan, R. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.10.009 · Cited by 82
Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
Morgan Rouprêt, A., Hupertan, V., Catto, J. W. F., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23196 · Cited by 82
Assessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
Valenzuela, M., Galisteo, R., Zuluaga, A., Villalobos, M., Núñez, M. I., Oliver, F. J., & de Almodóvar, J. M. R. (2002) · European Urology · doi:10.1016/s0302-2838(02)00468-2 · Cited by 82
Chan, K. C. A., Leung, S. F., Yeung, S.-W., Chan, A. T. �., & Lo, Y. M. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0182 · Cited by 80
Methylation profile of circulating plasma DNA in patients with pancreatic cancer
Melnikov, A. A., Scholtens, D. M., Talamonti, M., Bentrem, D. J., & Levenson, V. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21208 · Cited by 80
Bryzgunova, O. E., Morozkin, E. S., Yarmoschuk, S. V., Vlassov, V. V., & Laktionov, P. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.039 · Cited by 76
García-Olmo, D. C., Ruiz-Piqueras, R., & García‐Olmo, D. (2004) · PubMed · doi:10.14670/hh-19.575 · Cited by 71
Jian, G., Zhou, S., Ling, Z., Qinfang, D., Jie, Z., Liang, T., & Caicun, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0785-z · Cited by 70
Ellinger, J., Bastian, P. J., Ellinger, N., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.038 · Cited by 70
Matuschek, C., Bölke, E., Lammering, G., Gerber, P. A., Peiper, M., Budach, W., Taskin, H., Prisack, H.-B., Schieren, G., Orth, K., et al. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-7-277 · Cited by 65
Pinzani, P., Salvianti, F., Cascella, R., Massi, D., GIORGI, V. D., Pazzagli, M., & Orlando, C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.05.024 · Cited by 65
Taback, B., O'Day, S. J., Boasberg, P. D., Shu, S., Fournier, P., Elashoff, R. E., Wang, H., & Hoon, D. S. �. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh011 · Cited by 64
Self-citationIllades‐Aguiar, B., Alarcón‐Romero, L. D. C., Antonio-Véjar, V., López, N. Z., Sales-Linares, N., Flores‐Alfaro, E., Fernández‐Tilapa, G., Vences-Velázquez, A., Muñóz-Valle, J. F., & Leyva‐Vázquez, M. A. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.036 · Cited by 62
Bruhn, N., Beinert, T., Oehm, C., Jandrig, B., Petersen, I., Xiaowei, C. H. E. N., Possinger, K., & Fleischhacker, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06594.x · Cited by 60
Schwarzenbach, H., Pantel, K., Kemper, B., Beeger, C., Otterbach, F., Kimmig, R., & Kasimir‐Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2404 · Cited by 60
Self-citationTumor p16M is a possible marker of advanced stage in non–small cell lung cancer
Ng, C. S. H., Zhang, J., Wan, S., Lee, T. W., Arifi, A. A., Mok, T. S. K., Lo, D., & Yim, A. P. C. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10046 · Cited by 58
Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
Schwarzenbach, H., Chun, F. K. ‐., Lange, I., Carpenter, S. W., Gottberg, M., Erbersdobler, A., Friedrich, M. G., Huland, H., & Pantel, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22470 · Cited by 58
Self-citationPrognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
Lefébure, B., Charbonnier, F., Fiore, F. D., Tuech, J., Pessot, F. L., Michot, F., Michel, P., & Frébourg, T. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c35c87 · Cited by 53
Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
Fujimoto, A., O'Day, S. J., Taback, B., Elashoff, D. A., & Hoon, D. S. �. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0957 · Cited by 53
Self-citationClinical Biomarkers in Oncology: Focus on Colorectal Cancer
Roock, W. D., Biesmans, B., Schutter, J. D., & Tejpar, S. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256319 · Cited by 52
Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
Deligezer, U., Yaman, F., Erten, N., & Dalay, N. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00279-1 · Cited by 46
Pinzani, P., Mazzini, C., Salvianti, F., Massi, D., Grifoni, R., Paoletti, C., Ucci, F., Molinara, E., Orlando, C., Pazzagli, M., et al. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e32833906e3 · Cited by 45
Microsatellite analysis of serum DNA in patients with head and neck cancer
Nawroz, H., Eisenberger, C. F., Yoo, G. H., Wu, L., Koch, W. M., Black, C., Ensley, J. F., Wei, W., & Sidransky, D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20240 · Cited by 39
Zheng, Y. G., Wu, J., Chen, Z., & Goodman, M. (2008) · ChemInform · doi:10.1002/chin.200847259 · Cited by 37
Analysis of Methylated Genes in Peritoneal Fluids of Ovarian Cancer Patients: A New Prognostic Tool
Müller, H. M., Millinger, S., Fiegl, H., Goebel, G., Ivarsson, L., Widschwendter, A., Müller‐Holzner, E., Marth, C., & Widschwendter, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.034090 · Cited by 36
Circulating Nucleic Acids in Plasma and Serum
Gahan, P. B. (2010) · Springer eBooks · doi:10.1007/978-90-481-9382-0 · Cited by 35
O’Driscoll, L., Kenny, E. M., Mehta, J. P., Doolan, P., Joyce, H., Gammell, P., Hill, A. D. K., O’Daly, B., O’Gorman, D. J., & CLYNES, M. M. (2008) · PubMed · Cited by 34
Taback, B., Giuliano, A. E., Hansen, N. M., Singer, F. R., Shu, S. T., & Hoon, D. S. �. (2003) · PubMed · Cited by 30
Self-citationTP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin’s lymphoma
Hosny, G., Farahat, N. M. G., & Hainaut, P. L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.029 · Cited by 30
Effect of Adjuvant Chemotherapy on Integrity of Free Serum DNA in Patients with Breast Cancer
Deligezer, U., Eralp, Y., Akisik, E. Z., Akişık, E. E., Saip, P. M., Topuz, E., & Dalay, N. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.010 · Cited by 28
Salani, R., Davidson, B., Fiegl, M., Marth, C., Müller‐Holzner, E., Gastl, G. A., Huang, H.-Y., Hsiao, J.-C., Lin, H.-S., Wang, T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0853 · Cited by 25
Yu, K. H., Lo, Y. M. D., Tse, G. M.-K., Chan, K. C. A., Chan, A. B. W., Chow, K. C., Ma, T. K. F., Vlantis, A. C., Leung, S. F., van Hasselt, C. A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0991-3 · Cited by 25
Cited by
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Metadata
- Authors
- Schwarzenbach, H., Hoon, D. S. B., & Pantel, K.
- Venue
- Nature Reviews Cancer
- Published
- 2011-05-12
- Volume
- 11
- Issue
- 6
- Pages
- 426-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1963853602
- Cited by
- 2,891
- References
- 166
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.